Alpha lipoic acid for kidney protection during colistin treatment
Part of Kidney & urinary clinical trials.
This trial tests whether taking alpha lipoic acid (an antioxidant) alongside the antibiotic colistin can help protect the kidneys from damage. It may be helpful for patients who need colistin to fight a serious bacterial infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- You are currently receiving colistin through an IV (into a vein) for a bacterial infection.
- You have been on colistin for at least 3 days.
- You do not have kidney problems before starting colistin (no acute kidney injury, no chronic kidney disease, no dialysis, no kidney transplant).
- You are not taking other drugs that can harm the kidneys (like vancomycin, gentamicin, amikacin, or amphotericin B).
- You are not taking other antioxidants (like vitamin C, vitamin E, or N-acetyl cysteine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supplement called alpha-lipoic acid can help protect your kidneys from damage caused by cisplatin, a common chemotherapy drug. If it works, it could reduce side effects and help you tolerate your cancer treatment better.
This trial tests whether taking vitamin C and rutin (a plant compound) together can help protect the kidneys from damage caused by the antibiotic vancomycin. It compares this combination to vitamin C alone and to no extra supplement.
This trial tests whether taking vitamin C and coenzyme Q10 can help protect your kidneys while you receive chemotherapy with cisplatin and gemcitabine. It may reduce the risk of kidney damage from these treatments.
This trial tests if a supplement called L-carnitine can help prevent kidney damage caused by the chemotherapy drug cisplatin. It may be an option for newly diagnosed cancer patients who need cisplatin treatment.
This trial tests if alpha lipoic acid, a common supplement, can help reduce stress on the body for children who are on regular hemodialysis. It may offer a way to support their health during treatment.
This trial is testing a way to give the antibiotic colistin (which fights hard-to-treat infections) more personally to premature newborns, based on each baby's own body. The goal is to make the treatment safer and more effective for babies who are very sick in the neonatal intensive care unit (NICU).
Hear when a new Nephrotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.